Meso Numismatics Inc (MSSV)
0.0449
+0.01
(+24.72%)
USD |
OTCM |
May 10, 15:20
Meso Numismatics Cash from Financing (TTM): -0.3099M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.3099M |
September 30, 2023 | -0.0163M |
June 30, 2023 | -0.0178M |
March 31, 2023 | -0.0292M |
December 31, 2022 | -0.0208M |
September 30, 2022 | 0.9844M |
June 30, 2022 | 0.7354M |
March 31, 2022 | 11.25M |
December 31, 2021 | 12.15M |
September 30, 2021 | 11.23M |
June 30, 2021 | 11.74M |
Date | Value |
---|---|
March 31, 2021 | 1.364M |
December 31, 2020 | 0.5169M |
September 30, 2020 | 0.5087M |
June 30, 2020 | 0.3383M |
March 31, 2020 | 0.3451M |
December 31, 2019 | 0.3549M |
September 30, 2019 | 0.3575M |
June 30, 2019 | 0.3397M |
March 31, 2019 | 0.3054M |
December 31, 2018 | 0.2717M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.3099M
Minimum
Dec 2023
12.15M
Maximum
Dec 2021
2.727M
Average
0.3575M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
CEL-SCI Corp | 8.678M |
AIM ImmunoTech Inc | 0.485M |
IGC Pharma Inc | 2.856M |
NovaBay Pharmaceuticals Inc | 1.91M |
Protalix BioTherapeutics Inc | 24.67M |